Dermatologists Often Undervalue Depression, Anxiety in Patients

This article originally appeared here.
Share this content:
Dermatologists Often Undervalue Depression, Anxiety in Patients
Dermatologists Often Undervalue Depression, Anxiety in Patients

WEDNESDAY, Dec. 27, 2017 (HealthDay News) -- Dermatologists across Europe tend to underestimate mood disorders in their patients, according to a study published online Dec. 16 in the British Journal of Dermatology.

Florence J. Dalgard, from Lund University in Sweden, and colleagues estimated the agreement between clinical assessment of depression and anxiety by a dermatologist and patients' self-reported responses to the Hospital Anxiety and Depression Scale (HADS).

Based on data from 3,635 patient consultations, the researchers found that the agreement between dermatologist and HADS was poor to fair for all categories. The percentage of dermatologists recognizing signs of depression or anxiety, as assessed by HADS-value ≥11, was 44 percent for depression and 35.6 percent for anxiety, while 56 percent of dermatologists did not detect depression in nondepressed patients and 64.4 percent did not detect anxiety in nonanxious patients.

"The results point out that further training for dermatologists to improve their skills in diagnosing depression and anxiety might be appropriate," the authors write. "The psychological suffering of dermatological patients needs to be addressed when present."

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters


More in Home

CDC: Birth Rate for 10- to-14-Year-Olds at Record Low in 2016

CDC: Birth Rate for 10- to-14-Year-Olds at Record ...

Reduction in birth rates for all race and Hispanic origin groups; largest decline in non-Hispanic blacks

Lonafarnib May Lower Mortality in Hutchinson-Gilford Progeria

Lonafarnib May Lower Mortality in Hutchinson-Gilford Progeria

Lower mortality seen with lonafarnib monotherapy after 2.2 years compared with no treatment

About 40 Percent of Men Report Experiencing Weight Stigma

About 40 Percent of Men Report Experiencing Weight ...

Experience of weight stigma associated with increased odds of underweight or obesity

is free, fast, and customized just for you!

Already a member?

Sign In Now »